Category Added in a WPeMatico Campaign
First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY…
Read More »Commends the Trusts’ Boards for Working Constructively with Shareholders and Proposing a Shareholder-Friendly Combination LONDON–(BUSINESS WIRE)–Saba Capital Management, L.P. (together…
Read More »DUESSELDORF, Germany–(BUSINESS WIRE)–#DigitalSignage—SOLUM (KOSPI: 248070), a global retail solutions provider, and EWQ, a leading retail infrastructure innovator, have announced the…
Read More »DALLAS–(BUSINESS WIRE)–Kosmos Energy (NYSE/LSE: KOS) (“Kosmos” or the “Company”) is pleased to confirm that the license extensions for the West…
Read More »– First and only all-oral, fixed-duration regimen designed to provide CLL patients with the potential to experience time off treatment…
Read More »– Filing acceptance based on Phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death…
Read More »
If you’re looking for the best CTR manipulation tools that work with high CPC (cost per click) keywords, parasites, Linkedin,…
Read More »
NextTechJobs has launched an AI-driven job search platform for IT professionals in the USA, UK, and Canada. The service automates…
Read More »NEW YORK, Feb. 19, 2026 /PRNewswire/ — Better Business Advice has recognised Intuit’s QuickBooks Payroll as one of the best…
Read More »NORWALK, Conn.–(BUSINESS WIRE)–Xerox Holdings Corporation (NASDAQ: XRX) announced today that its board of directors declared a quarterly dividend of $0.025…
Read More »